Scientists test if antibody drug alters COVID vaccine power
NCT ID NCT04852978
Summary
This study aimed to understand if giving a monoclonal antibody treatment (casirivimab+imdevimab) around the same time as the Moderna COVID-19 vaccine affects how well the vaccine works. Researchers enrolled 295 healthy adults to measure the immune response and safety when these two treatments were given in close succession. The goal was to gather knowledge about potential interactions, not to directly treat or prevent disease in participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Regeneron Research Site
Little Rock, Arkansas, 72211, United States
-
Regeneron Research Site
Rogers, Arkansas, 72758, United States
-
Regeneron Research Site
Hialeah, Florida, 33012, United States
-
Regeneron Research Site
Miami, Florida, 33186, United States
-
Regeneron Research Site
Orlando, Florida, 32789, United States
-
Regeneron Research Site
Dayton, Ohio, 45417, United States
Conditions
Explore the condition pages connected to this study.